Advancing Hypertension Treatment through the Polypill Trial

Sri Lanka has emerged as a significant contributor to cutting-edge clinical trials, including a recent trial focusing on hypertension. Led by the Clinical Trials Unit at the University of Kelaniya, this ongoing multinational study aims to evaluate a novel treatment approach for hypertension, leveraging the benefits of a polypill. Sri Lanka's involvement in the trial has been substantial, playing a crucial role in ensuring the trial's success and efficacy.

Hypertension, a prevalent cardiovascular condition, presents challenges related to complex treatment regimens and poor adherence. The trial addresses these issues by exploring the effectiveness and safety of a single capsule containing multiple antihypertensive drugs. This innovative approach aims to improve treatment adherence, optimize blood pressure control, and potentially revolutionize hypertension management.

RemediumOne has managed more than 4 polypill trials

Polypill trials in hypertension have gained significant attention in recent years. The concept of a polypill, which combines multiple medications in a single pill, offers the potential for simplified treatment regimens and improved patient adherence. By combining different classes of antihypertensive drugs into a single formulation, the polypill approach aims to enhance convenience and effectiveness in blood pressure management.

The trial in Sri Lanka, coordinated by the Clinical Trials Unit, follows a rigorous research protocol. Participants diagnosed with hypertension are carefully monitored throughout the trial, with regular assessments of blood pressure levels and other relevant clinical parameters. The data collected from this multinational cohort, including participants from Sri Lanka, will be analyzed to evaluate the polypill’s effectiveness in reducing blood pressure and its safety profile.

The involvement of Sri Lanka in this groundbreaking trial reflects the country’s commitment to advancing medical research and enhancing healthcare outcomes. By actively contributing to cutting-edge clinical trials, Sri Lanka is fostering scientific progress and contributing to the development of innovative treatment approaches for hypertension and other critical medical conditions. The findings of this trial have the potential to shape the future of hypertension management and improve the lives of millions affected by this condition worldwide.

Recent Blogs
Cancer is the second most common cause of hospital deaths in Sri Lanka
February 20, 2024
Prof Siddharthan Chandran visited RemediumOne
February 19, 2024
3rd South Asia Forum for Clinical Development, Colombo, Sri Lanka
December 19, 2023
Make a difference tomorrow
Get in touch with us